Lipidomic analysis is able to measure simultaneously thousands of compounds belonging to a few lipid classes. In each lipid class, compounds differ only by the acyl radical, ranging between C10:0 (capric acid) and C24:0 (lignoceric acid). Although some metabolites have a peculiar pathological role, more often compounds belonging to a single lipid class exert the same biological effect. Here, we present a lipidomics workflow that extracts the tandem mass spectrometry data from individual files and uses them to group compounds into structurally homogeneous clusters by chemical structure hierarchical clustering analysis (CHCA). The case-to-control peak area ratios of the metabolites are then analyzed within clusters. We created two freely available applications to assist the workflow: FragClust to generate the tables to be subjected to CHCA, and TestClust to perform statistical analysis on clustered data. We used the lipidomics data from the plasma of Alzheimer's disease (AD) patients in comparison with healthy controls to test the workflow. To date, the search for plasma biomarkers in AD has not provided reliable results. This article shows that the workflow is helpful to understand the behavior of whole lipid classes in plasma of AD patients. [Figure not available: see fulltext.]

Di Gaudio, F., Indelicato, S., Monastero, R., Altieri, G., Fayer, F., Palesano, O., et al. (2016). FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 408(9), 1-12 [10.1007/s00216-015-9229-6].

FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease

DI GAUDIO, Francesca;INDELICATO, Sergio;MONASTERO, Roberto;ALTIERI, Grazia Ida;FAYER, Francesca;PALESANO, Ornella;FONTANA, Manuela;CEFALU', Angelo Baldassare;GRECO, Massimiliano;BONGIORNO, David;INDELICATO, Serena;ARONICA, Angela;NOTO, Davide;AVERNA, Maurizio
2016-01-01

Abstract

Lipidomic analysis is able to measure simultaneously thousands of compounds belonging to a few lipid classes. In each lipid class, compounds differ only by the acyl radical, ranging between C10:0 (capric acid) and C24:0 (lignoceric acid). Although some metabolites have a peculiar pathological role, more often compounds belonging to a single lipid class exert the same biological effect. Here, we present a lipidomics workflow that extracts the tandem mass spectrometry data from individual files and uses them to group compounds into structurally homogeneous clusters by chemical structure hierarchical clustering analysis (CHCA). The case-to-control peak area ratios of the metabolites are then analyzed within clusters. We created two freely available applications to assist the workflow: FragClust to generate the tables to be subjected to CHCA, and TestClust to perform statistical analysis on clustered data. We used the lipidomics data from the plasma of Alzheimer's disease (AD) patients in comparison with healthy controls to test the workflow. To date, the search for plasma biomarkers in AD has not provided reliable results. This article shows that the workflow is helpful to understand the behavior of whole lipid classes in plasma of AD patients. [Figure not available: see fulltext.]
2016
Settore MED/09 - Medicina Interna
Settore MED/26 - Neurologia
Di Gaudio, F., Indelicato, S., Monastero, R., Altieri, G., Fayer, F., Palesano, O., et al. (2016). FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 408(9), 1-12 [10.1007/s00216-015-9229-6].
File in questo prodotto:
File Dimensione Formato  
FragClust and TestClust.pdf

Solo gestori archvio

Descrizione: Articolo
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/183602
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact